Literature DB >> 7605627

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

P C Wong1, C A Pardo, D R Borchelt, M K Lee, N G Copeland, N A Jenkins, S S Sisodia, D W Cleveland, D L Price.   

Abstract

Mutations in Cu/Zn superoxide dismutase (SOD1) cause a subset of cases of familial amyotrophic lateral sclerosis. Four lines of mice accumulating one of these mutant proteins (G37R) develop severe, progressive motor neuron disease. At lower levels of mutant accumulation, pathology is restricted to lower motor neurons, whereas higher levels cause more severe abnormalities and affect a variety of other neuronal populations. The most obvious cellular abnormality is the presence in axons and dendrites of membrane-bounded vacuoles, which appear to be derived from degenerating mitochondria. Since multiple lines of mice expressing wild-type human SOD1 at similar and higher levels do not show disease, the disease in mice expressing the G37R mutant SOD1 must arise from the acquisition of an adverse property by the mutant enzyme, rather than elevation or loss of SOD1 activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605627     DOI: 10.1016/0896-6273(95)90259-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  400 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.

Authors:  P Pasinelli; M K Houseweart; R H Brown; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 4.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 5.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

6.  Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Authors:  Andrea Crotti; Christopher Benner; Bilal E Kerman; David Gosselin; Clotilde Lagier-Tourenne; Chiara Zuccato; Elena Cattaneo; Fred H Gage; Don W Cleveland; Christopher K Glass
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

7.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

8.  Intricate interplay between astrocytes and motor neurons in ALS.

Authors:  Hemali P Phatnani; Paolo Guarnieri; Brad A Friedman; Monica A Carrasco; Michael Muratet; Sean O'Keeffe; Chiamaka Nwakeze; Florencia Pauli-Behn; Kimberly M Newberry; Sarah K Meadows; Juan Carlos Tapia; Richard M Myers; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

9.  Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse.

Authors:  Lijun Wang; Han-Xiang Deng; Gabriella Grisotti; Hong Zhai; Teepu Siddique; Raymond P Roos
Journal:  Hum Mol Genet       Date:  2009-02-19       Impact factor: 6.150

10.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.